Vericel (VCEL) President & CEO On Sports Medicine & Severe Burn Care Therapies

Vericel (VCEL) is a commercial-stage biopharma company that focuses on sports medicine and severe burn care therapies. President and CEO, Nick Colangelo discusses VCEL as it expects an accelerated commercial launch for arthroscopic Maci. he notes that VCEL anticipates an accelerated potential commercial launch of arthroscopic Maci in 2024. He then goes over how VCEL announced FDA approval of Nexobird, U.S. commercial availability expected in 2Q23. Tune in to find out more about the stock market today.